As South Carolina public health officials work to stop the spread of measles following the current outbreak in the state, CVS ...

Given many Americans’ poor experiences with the healthcare system, CVS now hopes its new “engagement as a service” platform ...

CVS Health on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady ...

CNBC’s Jim Cramer sits down with CVS Health CEO David Joyner to discuss the company's investor day, how healthcare technology ...

CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...

CVS Health raised its 2025 revenue outlook to at least $397.3B and projected $400B+ the following year, winning multiple analyst upgrades. The company is investing heavily in data and analytics, ...

CVS Health Corporation (NYSE:CVS) provides healthcare solutions through insurance, pharmacy benefit management, and retail ...

Jim Cramer says he salutes CVS chief executive David Joyner. His remarks arrive after CVS raised its profit guidance for 2026 ...

On the same day, RBC Capital maintained its Outperform rating and $93 price target on CVS Health Corporation (NYSE:CVS) ...

The healthcare giant expects its turnaround efforts to pay off as it raised its full-year outlook and expects that momentum ...

CVS Health’s narrative has shifted with a slightly higher fair value estimate, nudging from about $91.50 to roughly $92.40 ...

In addition to the updates for 2025, CVS offered its first look at expected earnings for 2026. The company said it ...